In recent years, the migraine market is anticipated to grow rapidly during the forecast period. Migraine is the world's 19th most prevalent cause of disability, according to the World Health Organization. Migraine sufferers take twice as many prescription drugs and visit doctors and emergency rooms twice as often as individuals who do not suffer from the condition. Migraine sufferers have also spent significantly more on healthcare. Migraine sufferers are observed to consume 2.5 times as many prescription drugs and have six times the number of diagnostic tests and services as non-migraine sufferers. As a result of the rising occurrence of migraine, more therapies are being used to provide relief, which serves to drive the entire market.

  • Data Bridge Market Research analyses that the migraine market was valued at USD 3.5 billion in 2021 and is expected to reach USD 4.83 billion by 2029, registering a CAGR of 4.10% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Get the sample copy of Report @- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-migraine-market

Global migraine market is segmented on the basis of type, symptoms, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

  • Episodic
  • Chronic

On the basis of type, the migraine market is segmented into episodic, and chronic.

Symptoms

  • Food Cravings
  • Depression
  • Fatigue
  • Frequent Yawning
  • Hyperactivity
  • Irritability
  • Neck Stiffness
  • Others

On the basis of symptoms, the migraine market is segmented into food cravings, depression, fatigue, frequent yawning, hyperactivity, irritability, neck stiffness, and others.

Treatment

  • Medication
  • Acupressure
  • Counseling
  • Hormone Therapy
  • Others

On the basis of treatment, the global migraine market is segmented into medication, acupressure, counseling, hormone therapy and others. Medication segment is further segmented into pain-relieving medications, and preventive medications. Pain-relieving medications are further sub-segmented into anti-nausea drugs, opioid medications, CGRP antagonists, ubrogepant, lasmiditan, dihydroergotamine, triptans, and pain relievers. Preventive medications are further sub-segmented into CGRP monoclonal antibodies, botox injections, anti-seizure drugs, antidepressants, and blood pressure-lowering medications.

Diagnosis

  • Computerized Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Others

On the basis of diagnosis, the migraine market is segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI), and others.

Route of Administration

  • Oral
  • Parenteral
  • Others

The route of administration segment for the migraine market is segmented into oral, parenteral and others.

 End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

On the basis of end-users, the migraine market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

On the basis of distribution channel, the migraine market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Highlight of Table of Content:

·        Chapter 1: Market overview

·        Chapter 2: Global Migraine Marketanalysis

·        Chapter 3: Regional analysis of the Global Migraine Market

·        Chapter 4: Market segmentation based on types and applications

·        Chapter 5: Revenue analysis based on types and applications

·        Chapter 6: Market share

·        Chapter 7: Competitive Landscape

·        Chapter 8: Drivers, Restraints, Challenges, and Opportunities

·        Chapter 9: Gross Margin and Price Analysis

Some of the major players operating in the migraine market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd.(Jerusalem)
  • Sanofi (France)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Eli Lilly and Company (US)
  • Merck & Co., Inc. (US)
  • Allergan (Ireland)
  • AstraZeneca (UK)
  • AbbVie Inc. (US)
  • WOCKHARDT (Mumbai)
  • Johnson & Johnson Private Limited (US)
  • Cipla Inc. (US)  
  • Amneal Pharmaceuticals LLC. (US)
  • Eisai Co., Ltd. (Japan)
  • Bausch Health Companies Inc. (Canada)
  • Abbott (US)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Merck KGaA (Germany)

Profound Questions Answered in this Report:

·       What is the growth rate of various stages in the value chain of the industry?

·       Which region has the highest growth rate and size of the emerging market by value in 2022?

·       Who are the competitive players in Global Migraine Market?

·       Which region has the largest share and degree of competition in the industry?

·       What is the CAGR of the market during the forecast period 2022 to 2029?

·       Which region is expected to hold the highest market share for the market?

·       What is the main driver of the Global Migraine Market?

·       What is sales volume, revenue, and price analysis of top players of the market?

·       What are the market opportunities and threats faced by the vendors in the industry?

·       What has been the impact of COVID-19 on the Global Migraine Market?

 

Asceses Full report@ https://www.databridgemarketresearch.com/reports/global-migraine-market

Browser Related Report@-

Acrochordon Treatment Market

Hemiballismus Treatment Market

 Cardiac Biomarkers Testing Market

Gigantism Drugs Market

Extracorporeal Membrane Oxygenation Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com